CDK8 and non-small cell lung carcinoma: In non-small cell lung cancer, CDK8/FBXW7-mediated NICD1 degradation can be competitively abolished by RFC4 (a DNA replication factor), which results in increased NICD1 stability and promotes NSCLC invasiveness.